![Ari VanderWalde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ari VanderWalde
Director Técnico/Científico/I+D en Vector Oncology Solutions LLC .
Cargos activos de Ari VanderWalde
Empresas | Cargo | Inicio |
---|---|---|
Vector Oncology Solutions LLC
![]() Vector Oncology Solutions LLC Investment ManagersFinance Founded in 2001 by John McFarland, Vector Oncology Solutions LLC is a leader of oncology specific biopharmaceutical development and commercial outsourcing services. The firm was formerly known as Acorn Research LLC and is located in Memphis, Tennessee. Their novel data repository comprised of aggregated clinical (EMR), patient reported outcomes, genomic, physician notes and billing data powers a broad array of retrospective and prospective HEOR projects that provide an understanding of current practices in oncology care. Vector Oncology also provides comprehensive clinical trial services with specific expertise in supporting and accelerating early phase clinical trials and providing real-world late stage services. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Vector Oncology Solutions LLC
![]() Vector Oncology Solutions LLC Investment ManagersFinance Founded in 2001 by John McFarland, Vector Oncology Solutions LLC is a leader of oncology specific biopharmaceutical development and commercial outsourcing services. The firm was formerly known as Acorn Research LLC and is located in Memphis, Tennessee. Their novel data repository comprised of aggregated clinical (EMR), patient reported outcomes, genomic, physician notes and billing data powers a broad array of retrospective and prospective HEOR projects that provide an understanding of current practices in oncology care. Vector Oncology also provides comprehensive clinical trial services with specific expertise in supporting and accelerating early phase clinical trials and providing real-world late stage services. | Finance |
- Bolsa de valores
- Insiders
- Ari VanderWalde